These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 30249691)

  • 1.
    Zaloumis SG; Cao P; Dini S; Davenport MP; Cromer D; Khoury DS; Fowkes FJI; McCaw JM; Simpson JA
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30249691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the Efficacy of Triple Artemisinin-Based Combination Therapies for Treating Plasmodium falciparum Malaria Patients Using Mathematical Modeling.
    Dini S; Zaloumis S; Cao P; Price RN; Fowkes FJI; van der Pluijm RW; McCaw JM; Simpson JA
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30150462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partner-Drug Resistance and Population Substructuring of Artemisinin-Resistant Plasmodium falciparum in Cambodia.
    Parobek CM; Parr JB; Brazeau NF; Lon C; Chaorattanakawee S; Gosi P; Barnett EJ; Norris LD; Meshnick SR; Spring MD; Lanteri CA; Bailey JA; Saunders DL; Lin JT; Juliano JJ
    Genome Biol Evol; 2017 Jun; 9(6):1673-1686. PubMed ID: 28854635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
    Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Variant PfCRT Isoform Can Contribute to
    Dhingra SK; Redhi D; Combrinck JM; Yeo T; Okombo J; Henrich PP; Cowell AN; Gupta P; Stegman ML; Hoke JM; Cooper RA; Winzeler E; Mok S; Egan TJ; Fidock DA
    mBio; 2017 May; 8(3):. PubMed ID: 28487425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar.
    Lohy Das JP; Kyaw MP; Nyunt MH; Chit K; Aye KH; Aye MM; Karlsson MO; Bergstrand M; Tarning J
    Malar J; 2018 Mar; 17(1):126. PubMed ID: 29566683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of plasmepsin II and plasmepsin III does not directly cause reduction in Plasmodium falciparum sensitivity to artesunate, chloroquine and piperaquine.
    Loesbanluechai D; Kotanan N; de Cozar C; Kochakarn T; Ansbro MR; Chotivanich K; White NJ; Wilairat P; Lee MCS; Gamo FJ; Sanz LM; Chookajorn T; Kümpornsin K
    Int J Parasitol Drugs Drug Resist; 2019 Apr; 9():16-22. PubMed ID: 30580023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
    Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
    Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.
    Spring MD; Lin JT; Manning JE; Vanachayangkul P; Somethy S; Bun R; Se Y; Chann S; Ittiverakul M; Sia-ngam P; Kuntawunginn W; Arsanok M; Buathong N; Chaorattanakawee S; Gosi P; Ta-aksorn W; Chanarat N; Sundrakes S; Kong N; Heng TK; Nou S; Teja-isavadharm P; Pichyangkul S; Phann ST; Balasubramanian S; Juliano JJ; Meshnick SR; Chour CM; Prom S; Lanteri CA; Lon C; Saunders DL
    Lancet Infect Dis; 2015 Jun; 15(6):683-91. PubMed ID: 25877962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development.
    Zaloumis S; Humberstone A; Charman SA; Price RN; Moehrle J; Gamo-Benito J; McCaw J; Jamsen KM; Smith K; Simpson JA
    Malar J; 2012 Aug; 11():303. PubMed ID: 22931058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viability Screen of LOPAC
    Tong JX; Ang SEL; Tan EHN; Tan KSW
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30718250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread.
    Woodrow CJ; White NJ
    FEMS Microbiol Rev; 2017 Jan; 41(1):34-48. PubMed ID: 27613271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and characterization of piperaquine, mefloquine and artemisinin derivatives triple-resistant Plasmodium falciparum in Cambodia.
    Mairet-Khedim M; Roesch C; Khim N; Srun S; Bouillon A; Kim S; Ke S; Kauy C; Kloeung N; Eam R; Khean C; Kul C; Chy S; Leang R; Ringwald P; Barale JC; Witkowski B
    J Antimicrob Chemother; 2023 Feb; 78(2):411-417. PubMed ID: 36508338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrahost modeling of artemisinin resistance in Plasmodium falciparum.
    Saralamba S; Pan-Ngum W; Maude RJ; Lee SJ; Tarning J; Lindegårdh N; Chotivanich K; Nosten F; Day NP; Socheat D; White NJ; Dondorp AM; White LJ
    Proc Natl Acad Sci U S A; 2011 Jan; 108(1):397-402. PubMed ID: 21173254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are k13 and plasmepsin II genes, involved in Plasmodium falciparum resistance to artemisinin derivatives and piperaquine in Southeast Asia, reliable to monitor resistance surveillance in Africa?
    Foguim Tsombeng F; Gendrot M; Robert MG; Madamet M; Pradines B
    Malar J; 2019 Aug; 18(1):285. PubMed ID: 31443646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for pyronaridine as a highly effective partner drug for treatment of artemisinin-resistant malaria in a rodent model.
    Henrich PP; O'Brien C; Sáenz FE; Cremers S; Kyle DE; Fidock DA
    Antimicrob Agents Chemother; 2014; 58(1):183-95. PubMed ID: 24145526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam.
    Thanh NV; Thuy-Nhien N; Tuyen NT; Tong NT; Nha-Ca NT; Dong LT; Quang HH; Farrar J; Thwaites G; White NJ; Wolbers M; Hien TT
    Malar J; 2017 Jan; 16(1):27. PubMed ID: 28086775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo piperaquine resistance developed rapidly in Plasmodium falciparum isolates in northern Cambodia compared to Thailand.
    Chaorattanakawee S; Lon C; Jongsakul K; Gawee J; Sok S; Sundrakes S; Kong N; Thamnurak C; Chann S; Chattrakarn S; Praditpol C; Buathong N; Uthaimongkol N; Smith P; Sirisopana N; Huy R; Prom S; Fukuda MM; Bethell D; Walsh DS; Lanteri C; Saunders D
    Malar J; 2016 Oct; 15(1):519. PubMed ID: 27769299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lumefantrine attenuates Plasmodium falciparum artemisinin resistance during the early ring stage.
    Kümpornsin K; Loesbanluechai D; de Cozar C; Kotanan N; Chotivanich K; White NJ; Wilairat P; Gomez-Lorenzo MG; Gamo FJ; Sanz LM; Lee MCS; Chookajorn T
    Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():186-190. PubMed ID: 34673330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and structure elucidation of a steroidal moiety from
    Pradhan D; Biswasroy P; Sahu DK; Ghosh G; Rath G
    J Biomol Struct Dyn; 2023 Jul; 41(11):4993-5006. PubMed ID: 35585777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.